Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic

news

Sep 19

Written By Mollie Rotmensch

Mollie Rotmensch

Researchers find potential new way to target lethal form of leukemia

What You Need to Know About Immune-Onc Therapeutics